Brief: Aptose Biosciences And Crystalgenomics Announce Issuance Of European Patent For CG-806
27/09/2018 12:13
Sept 27 (Reuters) - CrystalGenomics Inc 083790.KQ :
* APTOSE BIOSCIENCES AND CRYSTALGENOMICS ANNOUNCE ISSUANCE
OF
EUROPEAN PATENT FOR CG-806
* APTOSE BIOSCIENCES INC - PATENT IS EXPECTED TO PROVIDE
PROTECTION UNTIL END OF 2033
Source text for Eikon: ID:nGNXMgzmM
Further company coverage: 083790.KQ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CG Invites
See all newsBrief: Cg Invites Wins 5.6 Billion Won Order
Brief: Crystalgenomics Invites Divesting 4 Billion Won Worth Of Own Shares
Brief: Kumho Ht To Divest 28 Billion Won Worth Of Shares In Crystalgenomics
Brief: Aptose Biosciences, Crystalgenomics Announce Issuance Of Australian Patent
Brief: CrystalGenomics to raise 21.1 bln won via private placement